The Ravelcare IPO closed on December 3, 2025, with overwhelming investor demand — reportedly subscribed around 438 times on the final day. mint
This marks one of the strongest responses among recent small-cap and SME IPOs in India, reflecting strong investor interest in the company’s growth story.
📊 What Is Ravelcare & What the IPO Offered
- Ravelcare is a digital-first beauty and personal care brand, offering haircare, skincare, bodycare and scalp-care products
- The IPO was a fresh issue of 18,54,000 equity shares aimed at raising ₹24.10 crore
- Price band was set at ₹123 to ₹130 per share.
Demand Breakdown: Strong Across All Investor Categories
On Day 3 (final day of subscription), Ravelcare IPO subscription profile looked like this:
- Qualified Institutional Buyers (QIB): ~155.9×
- Non-Institutional Investors (NII): Demand reportedly reached very high levels (in some reports over 700×)
- Retail Individual Investors (RII): ~463.1×
Overall subscription across categories was cited around 437.6× to 438× on the final day.
What the Strong Subscription Means
- High investor confidence: Such massive oversubscription indicates strong belief in Ravelcare’s business model, growth prospects, and brand potential.
- Likely premium listing: With oversubscription this high, many analysts expect Ravelcare shares to list with a considerable premium over the issue price. Since demand far outstripped supply, allocation will be tight.
- Good sign for SME IPO market: For small-cap / SME IPOs, such strong response may draw more investor interest to similar upcoming IPOs — boosting overall SME-IPO market sentiment.
- Chance & risk for investors: Investors who get allotment may see high listing gains; but with limited shares allocated (due to heavy subscription), many may not get any — so success depends on allotment luck.
Important Context & Timelines
- The IPO window was December 1–3, 2025
- Allotment is scheduled to be finalised on December 4, 2025
- Successful applicants will have shares credited to their demat accounts by December 5, 2025.
- The shares are expected to list on the SME segment of BSE on December 8, 2025. mint
What Investors Should Watch Next
- Track the allotment status once finalised — given heavy oversubscription, many may not get shares.
- Watch for listing premium — high grey market premium (GMP) suggests potential listing gains.
- Post-listing performance will depend on how Ravelcare uses the funds (e.g. new manufacturing facility, marketing) and how the business scales.
